US Patent Issued to MINERVA BIOTECHNOLOGIES on Dec. 9 for "Anti-variable MUC1* antibodies and uses thereof" (Massachusetts, Hawaii Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,259, issued on Dec. 9, was assigned to MINERVA BIOTECHNOLOGIES Corp. (Waltham, Mass.).

"Anti-variable MUC1* antibodies and uses thereof" was invented by Cynthia Bamdad (Boston), Benoit Smagghe (Honolulu), Scott Moe (Sudbury, Mass.) and Thomas Jeon (Woburn, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are methods and compositions for the targeted delivery of therapeutic agents and multispecific antibodies or antibody fragments comprising a binding domain to MUC1* and a binding domain to CD3. The present disclosure also provides compositions comprising antibodies and methods for treating diseases and disorders such as cancer."...